Physician profile
David Green
NPI 1578591723
$2,096.03
in general payments reported to CMS, 2019-2025
12 companies · $163 in 2025
The $163 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $34.91 · 2020: $11.71 · 2022: $644 · 2023: $957 · 2024: $285 · 2025: $163.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,318 · Education: $87.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,317.83 |
| Education | $87.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,438.71 | 2022-2024 | Mako |
| Arcutis Biotherapeutics, INC. | $189.36 | 2023 | |
| Janssen Biotech, INC. | $105.39 | 2024 | Tremfya |
| Regeneron Healthcare Solutions, INC. | $93.60 | 2022 | |
| Genzyme Corporation | $74.30 | 2025 | |
| Revance Therapeutics, INC. | $71.49 | 2025 | Daxxify |
| Merz North America, INC. | $34.91 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $27.55 | 2024 | Sotyktu |
| Abbvie INC. | $17.26 | 2025 | |
| Medtronic, INC. | $16.48 | 2024 | Venaseal |
| Pfizer INC. | $15.27 | 2023 | |
| Medtronic Vascular, INC. | $11.71 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Green listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.